Effects of chitosan molecular weight on the physical and dissolution characteristics of amorphous curcumin–chitosan nanoparticle complex
Authors:
- 11 September 2017
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 44 (1) , 82-88
Abstract
Objective: To investigate the effects of varying molecular weight (MW) of chitosan (CHI) used in the complexation with curcumin (CUR) on the physical and dissolution characteristics of the amorphous CUR–CHI nanoparticle complex produced. Significance: Amorphous CUR–CHI nanoparticle complex (or CUR nanoplex in short) recently emerged as a promising bioavailability enhancement strategy of CUR attributed to its fast dissolution, supersaturation generation capability, and simple preparation. Existing CUR nanoplex prepared using low MW CHI, however, exhibited poor colloidal stability during storage. Herein we hypothesized that the colloidal stability could be improved by using CHI of higher MW. The effects of this approach on the nanoplex’s other characteristics were simultaneously investigated. Methods: The CUR nanoplex was prepared by electrostatically driven self-assembled complexation between CUR and oppositely charged CHI of three different MWs (i.e. low, medium, and high). Besides colloidal stability, the effects of MW variation were investigated for the nanoplex’s (1) other physical characteristics (i.e. size, zeta potential, CUR payload, amorphous state stability), (2) preparation efficiency (i.e. CUR utilization rate, yield), and (3) dissolutions under sink condition and supersaturation generation. Results: CUR nanoplex prepared using CHI of high MW exhibited improved colloidal stability, larger size, superior morphology, and prolonged supersaturation generation. On the other hand, the effects of MW variation on the payload, amorphous state stability, preparation efficiency, and dissolution under sink condition were found to be insignificant. Conclusions: Varying MW of CHI used was an effective means to improve certain aspects of the CUR nanoplex characteristics with minimal adverse effects on the others.Keywords
Funding Information
- GlaxoSmithKline
This publication has 27 references indexed in Scilit:
- Curcumin, a component of golden spice: From bedside to bench and backBiotechnology Advances, 2014
- Enhanced bioavailability and bioefficacy of an amorphous solid dispersion of curcuminFood Chemistry, 2014
- Curcumin–β-cyclodextrin inclusion complex: Stability, solubility, characterisation by FT-IR, FT-Raman, X-ray diffraction and photoacoustic spectroscopy, and food applicationFood Chemistry, 2014
- Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatmentBiomaterials, 2014
- Liposome encapsulation of curcumin: Physico-chemical characterizations and effects on MCF7 cancer cell proliferationInternational Journal of Pharmaceutics, 2014
- Therapeutic Roles of Curcumin: Lessons Learned from Clinical TrialsThe AAPS Journal, 2012
- Advances in Nanotechnology-Based Delivery Systems for CurcuminNanomedicine, 2012
- Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizerDrug Development and Industrial Pharmacy, 2010
- Bioavailability of Curcumin: Problems and PromisesMolecular Pharmaceutics, 2007
- Characterization of curcumin–PVP solid dispersion obtained by spray dryingInternational Journal of Pharmaceutics, 2004